JUN 29, 2017 7:00 AM PDT

Dual-labeled PSMA Ligand Delivers a Diagnosis-Therapy Combo Punch to Prostate Cancer

During its annual member meeting in June the Society of Nuclear Medicine and Molecular Imaging, an international body that promotes the science, technology and excellence in practice of nuclear medicine and molecular imaging, awarded the 2017 image of the year to a team of German researchers. The work provided by the group is a pictorial summary of data and images that showcase the three-stage application of a dual-labeled imaging probe designed for prostate cancer diagnosis.

Dual-labeled PSMA-inhibitors for PET/CT imaging and fluorescence-guided intraoperative identification of prostate cancer and metastases. Credit: Society of Nuclear Medicine and Molecular Imaging

Prostate is a small walnut-shaped gland that produces the sperm-transporting seminal fluid. About one out of seven men will be diagnosed with prostate cancer during his lifetime. When detected early, 90% prostate cancer is curable. Because treatment is highly individualized, molecular imaging technologies are dramatically improving staging and treatment planning: it helps to pinpoint the location of a tumor, and the extent of the disease. Information collected from scanning provides detail on the molecular properties of the disease and the phenotypes of the patients, which allow physicians to choose the most effective treatment plan among prostate-removal surgery, radiation therapy and chemotherapy.

What is special about the German researchers’ work is that their PSMA (prostate specific membrane antigen)-seeking probe is labeled with positron emitting isotope gallium-68 and an infrared dye for multimodality imaging purpose. This combo package combines the advantages of PSMA-based PET (positron emitting tomography) imaging, and intraoperative gamma and fluorescence imaging. The clear identification of tumor (its location, size and border with healthy tissue) helped surgeons plan and execute clean tumor resection. It represents a state-of-art technology in disease diagnosis and treatment strategizing that leads to improved clinical confidence and outcome.

Thumbnail image: a male patient diagnosed with prostate cancer. PSMA-specific PET imaging probe was shown localized on the cancer. Credit: Society of Nuclear Medicine and Molecular Imaging

Source: Society of Nuclear Medicine and Molecular Imaging

About the Author
  • Graduated with a bachelor degree in Pharmaceutical Science and a master degree in neuropharmacology, Daniel is a radiopharmaceutical and radiobiology expert based in Ottawa, Canada. With years of experience in biomedical R&D, Daniel is very into writing. He is constantly fascinated by what's happening in the world of science. He hopes to capture the public's interest and promote scientific literacy with his trending news articles. The recurring topics in his Chemistry & Physics trending news section include alternative energy, material science, theoretical physics, medical imaging, and green chemistry.
You May Also Like
OCT 14, 2019
Cell & Molecular Biology
OCT 14, 2019
Understanding How Life Could Have Arisen From RNA
Around 4 billion years ago, scientists think that life arose, and they have been trying to learn more about how that happened...
DEC 01, 2019
Cell & Molecular Biology
DEC 01, 2019
Using CRISPR/Cas9 to Modify Chemical Reactions in Cells
Since the CRISPR gene editor was created, researchers around the world have tweaked and refined the tool to use it in a variety of ways....
DEC 05, 2019
Chemistry & Physics
DEC 05, 2019
Cryonics: Science or Science Fiction?
Cryonics ("Cryo" related to Greek word for "cold") is a highly controversial method to deep freeze and store a deceased human body, hop...
JAN 27, 2020
Chemistry & Physics
JAN 27, 2020
Espresso, Scientifically
Everyone has their preferred way to make a cup of coffee, but for those who wish to become the master of espresso, now there's a highly scientific way...
JAN 28, 2020
Technology
JAN 28, 2020
Portable device analyzes microbes in the environment
Aquatic microbes often serve as challenge to study, after all, they are too tiny to detect. But, what if there was a device that can swiftly analyze aquati...
FEB 21, 2020
Cancer
FEB 21, 2020
Understanding cancer heterogeneity
A team of researchers from Cornell has taken an innovative approach to crack the diversity code of cancer cells. Using a statistical modeling technique mor...
Loading Comments...